| PTO- 1478 |
| Approved for use through 09/30/2021. OMB 0651-0009 |
| U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
| Serial Number: 97007228 |
| Filing Date: 09/01/2021 |
|
|
|
| SERIAL NUMBER | 97007228 |
|---|---|
| MARK INFORMATION | |
| *MARK | RESTORE IMMUNE HEALTH |
| STANDARD CHARACTERS | YES |
| USPTO-GENERATED IMAGE | YES |
| LITERAL ELEMENT | RESTORE IMMUNE HEALTH |
| MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
| REGISTER | Principal |
| APPLICANT INFORMATION | |
| *OWNER OF MARK | Statera Biopharma, Inc. |
| INTERNAL ADDRESS | Suite 201 |
| *MAILING ADDRESS | 2537 Research Blvd. |
| *CITY | Fort Collins |
| *STATE
(Required for U.S. applicants) | Colorado |
| *COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
| *ZIP/POSTAL CODE
(Required for U.S. and certain international addresses) | 80526 |
| *EMAIL ADDRESS | XXXX |
| LEGAL ENTITY INFORMATION | |
| TYPE | corporation |
| STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
| GOODS AND/OR SERVICES AND BASIS INFORMATION | |
| INTERNATIONAL CLASS | 005 |
| *IDENTIFICATION | Pharmaceutical preparations and compounds for use in immune modulation, oncology, infectious diseases; pharmaceutical preparations for the treatment or prevention of immune-mediated diseases, Crohn's disease, multiple sclerosis, viral infections, HIV/AIDS, cancer, cell growth related disorders, cell proliferation related disorders, inflammatory diseases, ulcerative diseases, autoimmune diseases, autism, dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; anti-infectives; anti-inflammatories; vaccines; pharmaceutical preparations and compounds for reducing side effects in cancer treatment; pharmaceutical preparations and compounds for stimulating the immune system in an immuno-compromised patient; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements |
| FILING BASIS | SECTION 1(b) |
| INTERNATIONAL CLASS | 041 |
| *IDENTIFICATION | Educational services, namely, conducting classes, seminars, conferences, and workshops and distributing printed course materials in conjunction therewith; providing on-line journals, namely, blogs in the medical, pharmaceutical and health fields |
| FILING BASIS | SECTION 1(b) |
| INTERNATIONAL CLASS | 042 |
| *IDENTIFICATION | Pharmaceutical and therapeutics research and development services for systemically delivered, locally active immune restorative conjugates, small molecules and peptides; research and development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the pharmaceutical, therapeutics and biotechnology fields; research and product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides in the field of human therapeutics; research services using a platform of biological research tools and techniques for use in the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases and fibrotic diseases with systemically delivered, locally active immune restorative conjugates, small molecules and peptides; pharmaceutical product development of systemically delivered, locally active immune restorative conjugates, small molecules and peptides |
| FILING BASIS | SECTION 1(b) |
| ATTORNEY INFORMATION | |
| NAME | Carey Kulp |
| ATTORNEY DOCKET NUMBER | CYT-TM003 |
| ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
| YEAR OF ADMISSION | XXXX |
| U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
| FIRM NAME | Volpe Koenig |
| INTERNAL ADDRESS | Suite 1800 |
| STREET | 30 South 17th Street |
| CITY | Philadelphia |
| STATE | Pennsylvania |
| COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
| ZIP/POSTAL CODE | 19103 |
| PHONE | 215-568-6400 |
| FAX | 2155686499 |
| EMAIL ADDRESS | trademarks@vklaw.com |
| OTHER APPOINTED ATTORNEY | Michael F. Snyder, John J. O'Malley, Laura S. Lipschutz, Douglas J. Bucklin |
| CORRESPONDENCE INFORMATION | |
| NAME | Carey Kulp |
| PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@vklaw.com |
| SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | dwolf@vklaw.com; dbucklin@vklaw.com; msnyder@vklaw.com; ckulp@vklaw.com |
| FEE INFORMATION | |
| APPLICATION FILING OPTION | TEAS Standard |
| NUMBER OF CLASSES | 3 |
| APPLICATION FOR REGISTRATION PER CLASS | 350 |
| *TOTAL FEES DUE | 1050 |
| *TOTAL FEES PAID | 1050 |
| SIGNATURE INFORMATION | |
| SIGNATURE | NOT PROVIDED |
| SIGNATORY'S NAME | NOT PROVIDED |
| SIGNATORY'S POSITION | NOT PROVIDED |
| DATE SIGNED | NOT PROVIDED |
| PTO- 1478 |
| Approved for use through 09/30/2021. OMB 0651-0009 |
| U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
| Serial Number: 97007228 |
| Filing Date: 09/01/2021 |
| The applicant's current Correspondence Information: |
| Carey Kulp |
|
PRIMARY EMAIL FOR CORRESPONDENCE:
trademarks@vklaw.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): dwolf@vklaw.com; dbucklin@vklaw.com; msnyder@vklaw.com; ckulp@vklaw.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |